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e examined the role of the AML1 transcription factor in the development of hematopoiesis in the paraaortic
planchnopleural (P-Sp) and the aorta–gonad–mesonephros (AGM) regions of mouse embryos. The activity of colony-
orming units of colonies from the P-Sp/AGM region was reduced severalfold by heterozygous disruption of the AML1 gene,
ndicating that AML1 functioned in a dosage-dependent manner to generate hematopoietic progenitors. In addition, no
ematopoietic progenitor activity was detected in the P-Sp/AGM region of embryos with an AML1 null mutation. Similar
results were obtained when a dispersed culture was first prepared from the P-Sp/AGM region before assay of the activity of
the colony-forming units. In a culture of cells with the AML1(1/1) genotype, both hematopoietic and endothelial-like cell
types emerged, but in a culture of cells with the AML1(2/2) genotype, only endothelial-like cells emerged. Interestingly,
introduction of AML1 cDNA into the P-Sp/AGM culture with the AML1(2/2) genotype partially restored the production
of hematopoietic cells. This restoration was observed for cultures prepared from 9.5-day postcoitum (dpc) embryos but not
for cultures prepared from 11.5-dpc embryos. Therefore, the population of endothelial-like cells capable of growing in the
AML1(2/2) culture would appear to contain inert but nonetheless competent hematogenic precursor cells up until at least
the 9.5-dpc period. All these results support the notion that the AML1 transcription factor functions to develop and
maintain hematogenic precursor cells in the embryonic P-Sp/AGM region. © 2000 Academic Press
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Hematopoiesis occurs in two waves during murine devel-
opment (Moore and Metcalf, 1970; Johnson and Moore,
1975; Dzierzak and Medvinsky, 1995). Primitive hemato-
poiesis first appears in the form of blood islands in the yolk
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All rights of reproduction in any form reserved.ac at 7.5 days postcoitum (dpc) and produces large primi-
ive erythrocytes with nuclei which express the embryonic
ype of globin protein. Subsequently, definitive hematopoi-
sis starts in the fetal liver at 11.5 dpc and produces small
nucleated erythrocytes which express the adult type of
lobin protein. Recent gene-targeting studies have demon-
trated that the origins of primitive and definitive hemato-
oiesis are distinct and that the functions of a set of
ranscription factors are indispensable for the development
f hematopoietic tissues (see a review by Shivdasani and
rkin, 1996). In the case of definitive hematopoiesis, tar-
eting of the c-myb gene (Mucenski et al., 1991), AML1
ene (also known as PEBP2aB or CBFA2) (Okuda et al.,
27
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28 Mukouyama et al.1996; Wang et al., 1996a; Okada et al., 1998), or PEBP2b/
CBFb gene (Sasaki et al., 1996; Wang et al., 1996b; Niki et
l., 1997) results in impairment of hematopoiesis in the
etal liver but does not affect primitive hematopoiesis in the
olk sac. AML1 and PEBP2b/CBFb encode the DNA-
binding and non-DNA-binding subunits, respectively, of
the heterodimeric transcription factor PEBP2/CBF (Miyoshi
et al., 1991; Kagoshima et al., 1993; Meyers et al., 1993;
Ogawa et al., 1993a,b; Wang et al., 1993; Bae et al., 1994). In
12.5-dpc embryos homozygously mutated for AML1,
PEBP2b/CBFb, or c-myb, no hematopoietic cells of the
rythroid or myeloid lineage are detected, although the
egakaryocytic lineage is spared in the case of c-myb
argeting. Since neither the embryonic stem cells of the
ML1(2/2) genotype nor those of the PEBP2b/CBFb(2/2)
genotype contribute to the generation of hematopoietic
cells in chimeric mice or in an in vitro differentiation
system, the defect caused by these mutations is considered
intrinsic to the hematopoietic progenitors themselves. In
agreement with this, no colony-forming units of colonies
(CFU-C) activity is detected in the liver of embryos mutated
homozygously in any one of the above three genes.
During a later stage of murine development, the site of
definitive hematopoiesis shifts from the liver to the spleen
and bone marrow where hematopoiesis persists throughout
life. Recent experiments employing organ culture and
transplantation have revealed that the bona fide origin of
definitive hematopoiesis is not the fetal liver. For instance,
multipotent hematopoietic precursors are detected in the
paraaortic splanchnopleural (P-Sp) region of embryos at 8.5
dpc (Godin et al., 1993; Cumao et al., 1996). Also, activities
uch as those of long-term repopulating-hematopoietic
tem cells (LTR-HSCs) are first detected in the aorta–
onad–mesonephros (AGM) region of embryos at 10.5 dpc
Medvinsky et al., 1993; Mu¨ller et al., 1994; Medvinsky and
zierzak, 1996). This is somewhat reminiscent of the
ituation in birds, in which hematopoietic progenitors of
mbryonic origin are derived from the paraaortic mesenchy-
al tissues (Dieterlen-Lievre and Martin, 1981; Cormier
nd Dieterlen-Lievre, 1988). Furthermore, organ culture of
he AGM has enabled amplification of the activities of
TR-HSCs, thereby establishing the AGM region as an
rigin of definitive hematopoiesis in murine embryos (Med-
insky and Dzierzak, 1996). LTR-HSCs are thought to move
nto the fetal liver from the AGM region either through
irculation or by direct migration.
Recently we reported the development of an in vitro
ystem for the cultivation of cells derived from the embry-
nic AGM region at 11.5 dpc (Mukouyama et al., 1998). By
dding combinations of cytokines including oncostatin M,
e were able to demonstrate the efficient in vitro expansion
f hematopoietic progenitors. The hematopoietic cells of
arious lineages, including erythroid, myeloid, and lym-
hoid cells, can proliferate and differentiate in this system.
urthermore, day 8 and day 12 CFU-S (spleen) activities are
etected in this culture system. Mutation of the genes
ssential for the development of blood cells often results in 1
Copyright © 2000 by Academic Press. All rightmbryonic lethality (reviewed by Shivdasani and Orkin,
996). If the embryos survive up to the stage at which the
-Sp/AGM region is formed, in vitro cultures from the
-Sp/AGM can be initiated. Thus, this culture system
rovides a valuable tool to study the function of genes
hich are essential for the development of definitive hema-
opoiesis in the P-Sp/AGM region.
Although abrogation of AML1 abolishes hematopoiesis in
the fetal liver as mentioned above, the role of the gene, if
any, in the development of P-Sp/AGM hematopoiesis is not
known. In this study, we addressed this question by using
the in vitro P-Sp/AGM culture system as well as embryonic
P-Sp/AGM tissue itself, both of which were derived from
mice mutated for AML1. The results indicate that AML1 is
indispensable and that it functions in a dosage-dependent
manner in hematopoietic development in the P-Sp/AGM
region. Thus, some impairment of the P-Sp/AGM-located
hematopoietic progenitors actually precedes the failure of
definitive hematopoiesis in the liver of AML1-mutated
embryos. Furthermore, we suggest that the hematogenic
precursor cells are contained in an inert form in the popu-
lation of endothelial-like cells which are capable of growing
in P-Sp cultures with mutated AML1 genotypes. Hemato-
poietic cells could be regenerated from the AML1-null
culture by the transfer of AML1 c-DNA.
MATERIALS AND METHODS
Cell Culture and Mouse Embryos
Targeting of the AML1 gene was described previously (Okada et
al., 1998). The P-Sp and AGM regions were excised from mouse
embryos at 9.5 and 11.5 dpc, respectively, under microscopic vision
as described previously (Donovan et al., 1986; Mukouyama et al.,
998). The tissues were washed once with 0.25% (wt/vol) trypsin in
epes-buffered saline (GIBCO BRL) and incubated in fresh trypsin
olution at 37°C for 15 min. The trypsin solution was aspirated and
ell aggregates were removed by passing the suspension through a
icropipette tip and the single cells were resuspended in Dul-
ecco’s modified Eagle medium supplemented with 15% (vol/vol)
eat-inactivated fetal calf serum. The total number of cells recov-
red from one embryo was counted and the cultures were started at
density of 1 3 105 cells/ml in a 3.5-cm-diameter gelatin-coated
ish (Falcon). The cytokines added were 100 ng/ml stem cell factor
SCF) (provided by Kirin Brewery), 1 ng/ml basic fibroblast growth
actor (GIBCO BRL), 10 ng/ml murine leukemia inhibitory factor
R&D systems), and 10 ng/ml murine oncostatin M (R&D sys-
ems). After incubation at 37°C in an atmosphere of 5% (vol/vol)
O2 for various lengths of time, the cells were processed for
nalysis. Living cells were photographed using a phase-contrast
icroscope (Nikon; IMT-2). In the case of nonadherent cells, these
ere collected from the culture medium and centrifuged onto a
icroscope glass slide using a Cytospin apparatus (Shandon) at 800
pm for 5 min. The cells on the slide were air-dried and stained
sing May–Gru¨enwald–Giemsa solution (GIBCO BRL) for 5 min.
Retrovirus Infection of Cells
The murine AML1b/PEBP2aB1 cDNA fragment (Bae et al.,
993) was inserted into a pMx vector (Onishi et al., 1996). BOSC23
s of reproduction in any form reserved.
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29AGM Hematopoiesis in AML1-Targeted Embryoscells for packaging ecotropic retroviruses were plated the night
before transfection. Transient transfection of BOSC23 cells with
plasmid DNA was performed by the lipofection method using the
Lipofectamine reagent (GIBCO BRL). The cells were incubated for
48 h and the supernatant was collected and used immediately for
infection. The growth medium was aspirated from the P-Sp/AGM
culture and the viral supernatant was added together with 10 mg/ml
olybrene (Sigma) and the set of cytokines. After 24 h of incuba-
ion, this virus-containing medium was replaced by standard
rowth medium. The cells were incubated for several more days
nd processed for analysis.
The efficiency of gene transfer was monitored as follows. The
uman granulocyte–macrophage colony-stimulating factor (GM-
SF) receptor cDNA was inserted into a pMx vector. The plasmid
as transfected into the BOSC23 cells and the retrovirus-
ontaining medium was used for infecting the P-Sp/AGM culture.
he positive cells for the protein expression were estimated flow-
ytometrically to be 46% (data not shown).
CFU-C Assay
This assay was performed as we described previously (Mukou-
yama et al., 1998, 1999). The nonadherent, floating cells were
collected from the medium of day 9 P-Sp/AGM culture. In one case,
the cells dispersed from the embryonic P-Sp/AGM regions were
used immediately. In either case, the total cell numbers recovered
were counted and 1 3 104 cells were seeded in a 3.5-cm-diameter
ish in triplicate. The culture medium contained a-minimal essen-
tial medium, 0.8% (wt/vol) methylcellulose, 30% (vol/vol) fetal
calf serum, 1% (wt/vol) deionized bovine serum albumin, 100 mM
-mercaptoethanol, 10 ng/ml IL-3, 100 ng/ml SCF, 100 ng/ml IL-6,
nd 2 U/ml erythropoietin. IL-3 was prepared as previously de-
cribed (Miyajima et al., 1987). IL-6 and erythropoietin were kindly
provided by Ajinomoto and Kirin Brewery, respectively. The num-
bers of colonies formed in one dish were counted on the 7th and
14th days of incubation. The actually observed colony numbers,
which varied from none to almost 100 per dish, are presented as
data after being converted to the numbers per embryo. Colonies
were observed through a phase-contrast microscope and their types
were determined based on their size, morphology, and color. The
authenticity of such colony classification was confirmed, when
necessary, by making a cytospin preparation of each colony.
Flowcytometry
The nonadherent cells were collected from the medium of day 9
P-Sp/AGM cultures, resuspended in phosphate-buffered saline and
filtered through a nylon mesh of 70 mm (Cell Strainer; Falcon) to
remove cell aggregates. The single-cell suspensions were incubated
with the respective antibody for 30 min on ice. The monoclonal
antibodies used were anti-Mac-1 (M1/70), anti-Gr-1 (RB6-8C5),
anti-Thy-1.2 (30-H12), anti-Ter119 (Ter-119), biotinylated anti-
CD45 (30F11.1), biotinylated anti-c-Kit (3C1), and FITC-conjugated
anti-Sca-1 (E13-161.7). All the above antibodies were purchased
from Pharmingen. The secondary antibody used was either FITC-
conjugated anti-rat IgG (Pierce) which detected Mac-1, Gr-1, Thy-
1.2, and Ter119; allophycocyanin-conjugated streptavidin (Molecu-
lar Probe) which detected CD45; or PE-conjugated streptavidin
(Pharmingen) which detected c-Kit. The labeled cells were analyzed
by FACSCalibur (Becton–Dickinson) and the number of cells
analyzed for each marker was 5 3 103.
In one case, the day 9 AGM culture was incubated with diacety-
lated low-density lipoprotein (Dil-Ac-LDL) for 6 h as described
Copyright © 2000 by Academic Press. All rightpreviously (Mukouyama et al., 1998). The nonadherent as well as
adherent cells were harvested from the dish by EDTA treatment and
processed for two-color (Dil-Ac-LDL and CD45) flow cytometry.
RESULTS
Hematopoietic Activity in the P-Sp/AGM Region
of AML1-Targeted Embryos
We first examined whether hematopoietic activity could
be detected in the P-Sp/AGM region of AML1-targeted
mouse embryos. The P-Sp and AGM regions were excised
from embryos at 9.5 and 11.5 dpc, respectively, and the
dispersed cells were plated onto semisolid medium. CFU-C
number was counted after 7 and 14 days of incubation
(Table 1). Significant activity of CFU-C was detected for the
P-Sp/AGM region of wild-type embryos. On the other hand,
no CFU-C activity was detected for any colony lineage from
the corresponding regions of AML1(2/2) embryos. In the
case of AML1(1/2) embryos, total CFU-C activity was
reduced to 40 to 20% of that of AML1(1/1) embryos. The
reduction in CFU-C activity in AML1(1/2) was observed
for each colony lineage of myeloid, erythroid, and mixed
types. This suggests that the defect in AML1(1/2) lies at
the level of the hematopoietic progenitors.
The results in Table 1 clearly indicate that the reported
lack of hematopoiesis in the liver of AML1(2/2) embryos is
actually preceded by a defect in hematopoiesis in the
P-Sp/AGM region. In addition, generation of hematopoietic
progenitors in the P-Sp/AGM region is dependent on the
level of AML1 as exemplified by the heterozygous embryos.
The P-Sp/AGM Culture from the AML1-Targeted
Embryo
Next, we investigated whether hematopoietic cells could
be generated in primary cultures of P-Sp/AGM prepared
from AML1-targeted embryos. Figure 1 shows the phase-
contrast micrographs of the AGM culture prepared at 11.5
dpc. In the case of the AML1(1/1) culture, large, flat,
polygonal cells occupied the dish on the third day of culture
(Fig. 1A). These cells represent endothelial-like cells, since
they incorporate Dil-Ac-LDL and express platelet endothe-
lial cell adhesion molecule-1 (Mukouyama et al., 1998).
Subsequently, on the fifth day, numerous small and round
cells with a phase-bright appearance emerged (Fig. 1B).
These round cells possessed the morphological characteris-
tics of hematopoietic cells as revealed by May–Gru¨enwald–
Giemsa staining of the cytospin preparations (data not
shown). Similarly, both endothelial-like and hematopoietic
cells were produced by 5-day cultures derived from
AML1(1/2) embryos (Fig. 1C). In contrast, the production
of hematopoietic cells was never observed in 5-day cultures
of AML1(2/2) embryos in which only endothelial-like cells
dominated (Fig. 1D). This feature persisted even when
cultivation was continued up to the 10th day. In addition,
identical results were obtained for the P-Sp cultures pre-
pared at 9.5 dpc from embryos with the corresponding
s of reproduction in any form reserved.
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30 Mukouyama et al.AML1 genotype (data not shown). Thus, we conclude that
he null mutation of AML1 permits the generation of
ndothelial-like but not hematopoietic cells in primary
ultures of the P-Sp/AGM region. The endothelial-like cells
ould grow irrespective of the AML1 genotype.
Dosage Effect of AML1 on the Generation of
Hematopoietic Cells in the P-Sp/AGM Culture
During prolonged incubation of the P-Sp/AGM culture,
hematopoietic cells, if any, began to detach from the cell
monolayer. When the nonadherent cells were collected from
the medium of 11.5-dpc AGM culture on the ninth day, the
total number of cells recovered from the AML1(1/2) culture
as one-fourth of that from the wild-type culture. To confirm
heir hematopoietic cell nature, the cells were stained with
onoclonal antibodies against various cell surface markers
nd the identical cell number was subjected to flow cyto-
etrical analysis (Fig. 2). The left represents the staining
rofiles of cells from the AML1(1/1) culture, whereas the
ight represents those from the AML1(1/2) culture. Although
he nature of marker-negative cells detected especially in the
ML1(1/2) culture is not clear at present, a significant
umber of cells were found to be positive for markers of
arious hematopoietic lineages such as Gr-1, Mac-1, Ter119,
hy-1, and CD45 in both cultures. In addition, c-Kit1 and
ca-11 cells were also identified. Thus, both differentiated as
ell as progenitor hematopoietic cells were liberated into the
edium. It should be noted that, in the case of the
ML1(1/2) culture, the number of cells positive for each
urface marker was reduced to 1/4 to 1/10 of that of the
ML1(1/1) culture. Therefore, the heterozygous mutation of
TABLE 1
CFU-C Activities in the P-Sp/AGM Region of AML1-Mutated Em
Source
Genotype
of AML1
Incubation
period
P-Sp region on 9.5 dpc 1/1 7 days
1/2
2/2
1/1 14 days
1/2
2/2
GM region on 11.5 dpc 1/1 7 days
1/2
2/2
1/1 14 days
1/2
2/2
Note. The 9.5-dpc P-Sp and 11.5-dpc AGM regions were dissecte
olonies were scored at 7 or 14 days after incubation. The number
2/2) genotypes, respectively, in the case of the 9.5-dpc P-Sp regio
enotypes, respectively, in the case of the 11.5-dpc AGM region. T
lassified as myeloid, erythroid, or mixed types.ML1 appears not to completely abolish hematopoiesis in the C
Copyright © 2000 by Academic Press. All rightGM culture but to reduce the level of generation of hema-
opoietic cells.
The expression of endothelial cell marker was examined
s well. The AGM culture was incubated with Dil-Ac-LDL
nd all the cells recovered from the culture, irrespective of
hether they were adherent or nonadherent, were pro-
essed for two-color flow cytometry (Fig. 3). The Dil-Ac-
DL1CD452 subpopulation corresponding to endothelial-
like cells was detected to a similar degree in all the
AML1(1/1), (1/2), and (2/2) cultures. On the other hand,
the percentage of CD451, hematopoietic subpopulation was
greatly reduced in the AML1(1/2) culture compared to the
wild type and was almost undetectable in the (2/2) culture.
The result confirms that the heterozygous disruption of
AML1 impairs the generation of hematopoietic but not
endothelial-like cells.
The results of flow cytometrical analysis then led us to
accurately quantify CFU-C activity in the P-Sp/AGM cul-
ture. On the ninth day of culture, the nonadherent cells
were collected and plated onto semisolid medium and
CFU-C activity was measured (Table 2). In the case of the
AML1(1/1) genotype, significant levels of CFU-C activity
were detected in both the P-Sp and the AGM cultures. On
the other hand, total CFU-C activity in the AML1(1/2)
culture was reduced to only 1 to 7% of that of the
AML1(1/1) culture. The cells collected from the
AML1(2/2) culture generated no CFU-C activity at all. A
similar result was obtained when the adherent as well as
nonadherent cells were collected from the dish and the
CD451 subpopulation purified from them was assayed for
the CFU-C activity (data not shown). Therefore, the dosage
effect of AML1 on hematopoiesis is clearly seen when
Number of colonies per embryo
eloid Erythroid Mixed Total
6 15.6 4.9 6 2.3 23.2 6 11.4 75.3 6 19.8
6 11.5 7.5 9.8 6 8.7 30.0 6 19.5
0 0 0 0
6 44.8 6.8 6 3.0 26.6 6 22.9 86.6 6 39.1
6 8.7 9.8 6 11.3 0 20.3 6 15.8
0 0 0 0
6 5.0 3.0 6 3.0 25.0 6 5.8 72.2 6 10.5
6 3.4 1.7 6 3.4 15.1 6 19.3 22.4 6 24.6
0 0 0 0
6 13.2 0.4 6 0.8 31.4 6 8.7 67.1 6 8.3
6 5.6 0 8.0 6 11.7 18.5 6 12.5
0 0 0 0
embryos, dispersed, and inoculated into methylcellulose media.
mbryos examined were 4, 5, and 4 for the AML1(1/1), (1/2) and
hereas they were 5, 9, and 4 for the AML1(1/1), (1/2) and (2/2)
sults represent the means 6 standard deviation. Each colony wasbryos
My
47.4
12.1
53.3
9.8
43.7
3.9
36.5
10.0
d from
s of e
n, w
he reFU-C is assayed using either the P-Sp/AGM culture (Table
s of reproduction in any form reserved.
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31AGM Hematopoiesis in AML1-Targeted Embryos2) or the embryonic P-Sp/AGM tissue itself (Table 1). The in
itro culture system is considered to reflect with fidelity
he hematopoietic activity residing in the embryo.
As stated in the Introduction, the defect caused by AML1
isruption is reported to be intrinsic to the hematopoietic
rogenitors themselves. In line with this, we could not
etect any inhibitory activity in the AGM region or the
GM culture of the AML1(2/2) genotype that could pre-
vent the detection of progenitor cells (data not shown). This
was confirmed by mixing the wild-type and AML1(2/2)
cells and assaying the CFU-C activity generated.
Restoration of Hematogenic Activity in AML1(2/2)
Cultures Complemented with the AML1 Gene
In our previous study, we suggested that certain members
of the endothelial-like cell population in AGM cultures
may possess latent hematogenic activity (Mukouyama et
l., 1998, 1999). It is noteworthy in this sense that the
ndothelial-like cells could still propagate in the P-Sp/AGM
ulture in the absence of AML1 (Fig. 1D). One of the
experimental advantages of using an in vitro culture system
is the ease with which such cultures can be complemented
with extraneous genes. We therefore examined whether
hematogenic activity could be restored to AML1(2/2) cul-
FIG. 1. Phase-contrast micrographs of tissue culture cells prepared
were (1/1) (A and B), (1/2) (C), and (2/2) (D). The number of cultutures after complementation with the AML1 gene. b
Copyright © 2000 by Academic Press. All rightThe murine AML1b/PEBP2aB1 cDNA was inserted into
retroviral vector and packaged into a retrovirus. On the
econd day of culture, the AML1(2/2) P-Sp region prepared
t 9.5 dpc was infected with the virus. Figure 4A shows the
icrograph of the culture after another 8 days of incuba-
ion. Interestingly, significant numbers of small and round
ells could be easily identified. These cells showed the
orphological characteristics of hematopoietic cells when
tained with the May–Gru¨enwald–Giemsa solution (Fig.
B). Furthermore, flow cytometrical analysis revealed the
xpression of hematopoietic markers such as Ter119 and
r-1/Mac-1 for a minor, but still significant, percentage of
onadherent cells (Fig. 5). As a control, the AML1(2/2)
ulture infected with the retrovirus harboring no AML1b
DNA produced no such cells (data not shown). The results
n Figs. 4 and 5 therefore suggest that hematogenic precur-
or cells still persist in the AML1(2/2) P-Sp culture pre-
ared at 9.5 dpc. It is likely that they remain inert in the
bsence of AML1 but that they can be reactivated to some
xtent for hematopoiesis when supplemented with the
ML1 gene.
It must be mentioned that the recovered “hematopoietic”
ells lacked expression of CD45, a panleukocyte marker,
nd c-Kit, a marker of progenitors (Fig. 5). In accordance
ith the lack of c-Kit expression, no CFU-C activity could
the AGM region of embryos at 11.5 dpc. The genotypes of AML1
days was 3 (A) or 5 (B, C, and D). Original magnification was 1003.frome detected in the AML1b/retrovirus-infected AML1(2/2)
s of reproduction in any form reserved.
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Copyright © 2000 by Academic Press. All rightculture (data not shown). Thus, hematopoietic activity was
recovered, but only partially under the present experimen-
tal condition.
The AML1(2/2) AGM culture prepared at 11.5 dpc was
also processed for AML1b/retrovirus infection. Interest-
ingly, no sign of hematopoiesis was detected at all in this
case (data not shown). This suggests that hematogenic
precursors detected in the AML1(2/2) P-Sp culture at 9.5
dpc are no longer proficient or are lost from the AGM
culture at 11.5 dpc.
DISCUSSION
No Hematopoietic Activity in the P-Sp/AGM
Region of AML1(2/2) Embryos
It has been established recently that definitive hemato-
FIG. 3. Flow cytometrical analysis of the hematopoietic as well as
the endothelial cell markers expressed in the AGM culture. The
AGM culture was prepared from one embryo for each AML1(1/1),
(1/2), and (2/2) genotype at 11.5 dpc. On the ninth day of culture,
the cells were incubated with (right) or without Dil-Ac-LDL (left).
The adherent as well as nonadherent cells were harvested from the
dish and processed for two-color (Dil-Ac-LDL and CD45) flow
cytometry. The numbers in quadrants represent the percentages of
each subpopulation.FIG. 2. Flow cytometrical analysis of the nonadherent cells derived
from the AGM culture. The AGM culture was prepared from one
embryo for each AML1(1/1) or (1/2) genotype at 11.5 dpc. The nonad-
erent cells were collected from the medium of day 9 culture and various
ell surface markers were examined as indicated. Thin lines represent the
uorescence from the reaction using only the fluorescence-conjugated
econdary antibody, whereas thick lines represent the fluorescence from
he reaction using both the primary and the secondary antibodies. We
ave repeated experiments two more times using embryos other thanpoiesis does not occur in the liver of embryos which are
s of reproduction in any form reserved.
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33AGM Hematopoiesis in AML1-Targeted Embryoshomozygously disrupted for either AML1 or PEBP2b/CBFb
(Okuda et al., 1996; Sasaki et al., 1996; Wang et al., 1996a,b;
Niki et al., 1997; Okada et al., 1998). As for the relationship
between the reported phenotype and P-Sp/AGM hemato-
poiesis, there are two possible explanations. One possibility
is that hematopoietic progenitors are generated in the
P-Sp/AGM region but are prevented from settling in the
liver of the mutated embryos. The second possibility is that
hematopoietic progenitors are not generated in the P-Sp/
AGM region, which would result in no influx of hemato-
poietic activity into the liver. We could detect no CFU-C
activity in the P-Sp/AGM region itself nor in P-Sp/AGM
cultures prepared from the AML1(2/2) or PEBP2b/
CBFb(2/2) (unpublished results, Y.M. and T.W.) embryos.
hus, the results are consistent with the second possibility.
Partial Defect in Hematopoiesis in the P-Sp/AGM
Region of AML1(1/2) Embryos
Although hematopoietic activity has been reported for
AML1(1/2) embryos, the subject has remained controver-
sial. In one study, CFU-C activity recovered from the liver
of AML1(1/2) embryos showed a 50% reduction compared
to the wild-type level (Wang et al., 1996a and our unpub-
lished results, H.O. and T.W.), whereas another study found
a similar activity of CFU-C between AML1(1/1) and (1/2)
fetal liver (Okuda et al., 1996). Our study revealed a more
severe reduction in CFU-C activity in the P-Sp/AGM region
and in cultures of this region from AML1(1/2) embryos.
The PEBP2b/CBFb protein is a non-DNA-binding partner
f AML1. As for the CFU-C activity detected in the fetal
iver, three previous reports including our own showed no
TABLE 2
CFU-C Activities in the P-Sp/AGM Culture Prepared from AML1-
Source
Genotype
of AML1
Incubation
period My
P-Sp region on 9.5 dpc 1/1 7 days 130.0
1/2 1.7
2/2
1/1 14 days 110.0
1/2 0.8
2/2
AGM region on 11.5 dpc 1/1 7 days 2162.5
1/2 124.3
2/2
1/1 14 days 2670.0
1/2 195.8
2/2
Note. The 9.5-dpc P-Sp and 11.5-dpc AGM regions were dissected
were collected from the media of day 9 culture and inoculated int
incubation. The numbers of embryos examined were 5, 8, and 4 fo
of 9.5-dpc P-Sp regions, whereas they were 4, 8, and 4 for the AML1
AGM region. The results represent the means 6 standard deviatioignificant difference between PEBP2b/CBFb(1/1) and
Copyright © 2000 by Academic Press. All right(1/2) cells (Sasaki et al., 1996; Wang et al., 1996b; Niki et
al., 1997). On the other hand, we observed an 80% reduc-
tion of CFU-C activity in the AGM culture of PEBP2b/
CBFb(1/2) embryos (unpublished results, Y.M. and T.W.).
Taking together the observations mentioned above, the
mounts of both subunits of the heterodimeric PEBP2/CBF
ranscription factor, namely AML1 and PEBP2b/CBFb, ap-
ear to be critical for the full generation of CFU-C activity,
t least in the case of P-Sp/AGM hematopoiesis. In addi-
ion, the P-Sp/AGM-residing progenitors are perhaps more
ensitive to the amount of PEBP2/CBF than the liver-
esiding progenitors.
Hematogenic Precursors Still Persist in 9.5-dpc
Embryos but Are Lost from 11.5 dpc in the
AML1(2/2) P-Sp/AGM Culture
The AML1(2/2) P-Sp culture prepared from embryos at
9.5 dpc was characterized by the complete absence of
hematopoietic cells. Interestingly, infection of this culture
with a retrovirus carrying the AML1 cDNA partially re-
stored the generation of hematopoietic cells. This suggests
that some kind of hematogenic precursor cells, although
not detected as the CFU-C activity under the present
experimental conditions, remained as an inert form among
the population of endothelial-like cells observed in the
AML1(2/2) P-Sp culture. We previously postulated the
existence of hematogenic endothelial-like cells, since on-
costatin M was absolutely found to be required for the
efficient production of both hematopoietic and endothelial-
like cells in AGM cultures (Mukouyama et al., 1998). There
have also been several other results which suggest the
ated Embryos
Number of colonies per embryo
Erythroid Mixed Total
7.2 10.7 6 7.0 66.6 6 10.2 207.3 6 6.4
0.8 0 0.4 6 0.4 2.1 6 0.6
0 0 0
24.3 8.0 6 2.0 104.7 6 14.0 222.7 6 30.0
0.8 0 1.7 6 0.6 2.5 6 0.6
0 0 0
23.1 626.8 6 155.9 670.3 6 38.0 3460.7 6 871.4
66.3 40.7 6 31.9 47.3 6 25.4 212.3 6 41.8
0 0 0
37.1 379.9 6 118.9 902.7 6 143.9 3955.0 6 528.9
49.5 47.3 6 27.5 47.3 6 25.4 275.0 6 55.0
0 0 0
embryos, dispersed, and cultured in vitro. The nonadherent cells
thylcellulose media. Colonies were scored at 7 and 14 days after
AML1(1/1), (1/2), and (2/2) genotypes, respectively, in the case
), (1/2), and (2/2) genotypes, respectively, in the case of 11.5-dpc
ch colony was classified as myeloid, erythroid, or mixed types.Mut
eloid
6
6
0
6
6
0
6 5
6
0
6 5
6
0
from
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r the
(1/1existence of hematogenic endothelial cells (Shalaby et al.,
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34 Mukouyama et al.1997; Choi et al., 1998; Jaffredo et al., 1998; Nishikawa et
al., 1998a,b). In line with these, the expression of AML1 in
some endothelial cells in the AGM region has also been
demonstrated recently by a strategy to introduce lac Z
coding sequences into the AML1 locus (North et al., 1999).
Direct demonstration of such presumptive precursor cells
remains for future studies. They include, for example, the
use of culture prepared at earlier than 9.5-dpc time points.
On the other hand, retrovirus infection did not restore
hematopoietic properties to cells of the AML1(2/2) AGM
culture prepared at 11.5 dpc. A plausible explanation would
be that the putative precursors to hematopoietic cells
(hematogenic endothelial cells) still persist to some degree
up until 9.5 dpc, but disappear before 11.5 dpc in P-Sp/AGM
FIG. 4. Introduction of AML1 cDNA into the AML1(2/2) P-Sp
ulture. (A) A microscopic image of the retrovirus-infected
ML1(2/2) P-Sp culture. The P-Sp region was excised from
ML1(2/2) embryos at 9.5 dpc and cultured for 2 days. Cells were
nfected with a retrovirus carrying AML1 cDNA and were then
cultured for a further 10 days. Note that numerous round hemato-
poietic cells were generated. (B) May–Gru¨enwald–Giemsa staining
of a cytospin preparation of hematopoietic cells produced by the
retrovirus-infected AML1(2/2) P-Sp culture. The cells were col-
lected from the culture medium described in A and cytocentri-
fuged. Note that most of the cells showed a differentiated morphol-
ogy and that few blastic cells were present.cultures of AML1(2/2). AML1 appears to be necessary for
Copyright © 2000 by Academic Press. All rightthe survival and maintenance of hematogenic precursors in
a competent form.
Comparison of AML1 with c-myb
Homozygous disruption of c-myb is also known to impair
definitive hematopoiesis in the fetal liver (Mucenski et al.,
991). Recently, we reported a study similar to the present
tudy on c-myb and the results can be summarized as
ollows (Mukouyama et al., 1999). (1) In the case of
-myb(1/1), immunostaining of c-Myb was never detected
n endothelial-like cells of AGM cultures. c-Myb staining
ecame obvious for the first time only in hematopoietic
ells. (2) In AGM cultures of c-myb(2/2) embryos, no
ematopoietic cells were produced. (3) Introduction of
-myb cDNA into the c-myb(2/2) AGM culture restored
he production of hematopoietic cells, although once again
nly to a limited extent. Unlike the case of AML1, however,
he restoration of hematopoiesis was possible even when
he culture was prepared from embryos at 11.5 dpc.
The absence of hematopoiesis in c-myb(2/2) AGM cul-
ures is reminiscent of AML1(2/2) cultures. The develop-
ental stage and/or target cells on which c-myb and AML1
ct are, however, probably distinct from each other. Hema-
opoietic cells themselves are considered the target for the
ivotal role of c-Myb. This notion is based on the expres-
ion pattern of c-Myb and on c-myb transfer experiments.
n contrast, and as discussed above, the putatively hemato-
enic, endothelial-like cells, are considered the most likely
andidate cells for the critical function of AML1. Thus, in
emporal terms, AML1 and c-myb seem to exert their
functions relatively early and late, respectively, in the
development of P-Sp/AGM hematopoiesis.
FIG. 5. Flow cytometrical analysis of hematopoietic cells pro-
duced by the retrovirus-infected AML1(2/2) P-Sp culture. The
cells were collected from the culture medium described in Fig. 4A
and processed for flow cytometrical analysis. Various cell surface
markers were examined as indicated. Thin lines represent the
fluorescence from the reaction using only the fluorescence-
conjugated secondary antibody, whereas thick lines represent the
fluorescence from the reaction using both the primary and the
secondary antibodies.
s of reproduction in any form reserved.
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In summary, the present study shows that the AGM
culture system is useful for the study of the function of
transcription factors in the development of definitive he-
matopoiesis. This is particularly true when the system
incorporates the use of gene manipulation, as shown here. It
will be important next to determine in molecular terms
how transcription factors contribute to the development of
definitive hematopoiesis. The determination of whether
interplay exists between AML1 and c-myb represents an
important challenge.
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